Medtronic cryocath was made aware of this event through a search of literature publications.It was not possible to ascertain specific device information from the literature publication or to match the event with previously reported events.This information is based entirely on journal literature.All information provided is included in this report.Patient information is limited due to confidentiality concerns.The baseline characteristics of the patients referenced in the article is gender/age is male/(b)(6) years old.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.Referenced article: koektuerk bd, yorgun h, turan ch, et al.Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation.Circ.Arrhythmia electrophysiol.2015;8(5):1073-1079.(b)(4).
|
Koektuerk bd, yorgun h, turan ch, et al.Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation.Circ.Arrhythmia electrophysiol.2015;8(5):1073-1079.Background - data regarding the freedom from atrial fibrillation (af) in the follow-up of persistent af patients is limited.The second-generation cryoballoon has better cooling properties compared with first-generation cryoballon.In this study, we aimed to assess the medium-term efficacy of second-generation cryoballoon in patients with persistent af.Methods and results - a total of 100 patients (63 +/- years, 80% male) with symptomatic persistent af, despite ?1 antiarrhythmic drug(s), who were scheduled for pulmonary vein isolation using second-generation cryoballoon were enrolled in this study.Follow-up was based on outpatient clinic visits, including holter ecgs.Recurrence was defined as a symptomatic or documented arrhythmia episode of >30 seconds excluding a 3-month blanking period.As a result, 393 pulmonary veins (7 patients with common ostium) were successfully isolated.Mean procedural and fluoroscopy times were 96.2 +/- 21.3 and 19.7 +/- 6.7 minutes, respectively.Phrenic nerve palsy occurred in 3% (3/100) of the patients.At a mean follow-up duration of 10.6 +/- 6.3 months, 67% of the patients were in sinus rhythm.Stepwise multivariable cox proportional hazard regression analysis showed that early af recurrence (hazard ratio 3.83, 95% confidence interval 1.91-7.68, the literature publication reports the following patient complications: three (3) patients who experienced "mild" pericardial effusion, which resolved spontaneously.No further patient complications have been reported as a result of this event.
|